Atrial Fibrillation Market Forecast by 2022 | Key Players include Abbott Laboratories, Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, St. Jude Medical, Inc. and Medtronic plc

Atrial Fibrillation Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $8,319 million by 2022, registering a CAGR of 13.0% during the period 2014 - 2022. Non-surgical devices segment dominated the overall market in 2015. North America was the leading geographic segment in global atrial fibrillation devices market in 2015, and is expected to maintain its leading position throughout forecast period.

Rise in prevalence rate of atrial fibrillation in geriatric population, technological advancements in devices, improvement of healthcare infrastructure in developing countries, development of minimally invasive procedures, and increase in patient awareness propel the market growth. However, dearth of skilled professionals and unfavorable preference to pharmaceutical drugs hamper the growth of the market.

Download Now! Sample PDF Brochure @ https://www.alliedmarketresearch.com/request-sample/479

Catheter ablation is the highest revenue contributor and is expected to grow at the highest CAGR of 13.8% in the analysis period. This growth is owing to the technological advancements such as cryoFORM, which offers increased flexibility that allows easy manipulation and treatment during surgical process. In addition, increase in preference of catheter ablation for cardiac arrhythmia treatment over other devices as this is the safer and minimally invasive surgical procedures used for the treatment of atrial fibrillation.

Asia-Pacific is expected to be the fastest growing region with a CAGR of 14.7% during the forecast period. Japan accounted for the highest share of the total Asia-Pacific market in 2015; while China is poised to grow at highest CAGR during the analysis period (20162022). This growth in this region is attributed to the rise in the prevalence of cardiac arrhythmia in developing countries (such as India and China) owing to the large geriatric population.

Key findings of the Atrial Fibrillation Market
•North America dominated the market of atrial fibrillation and is expected to maintain its lead throughout the forecast period, with a CAGR of 12.1%
•By country, U.S. generates the highest revenue in 2015
•Asia-Pacific is the fastest growing market and is estimated to grow at a CAGR of 14.7%
•Japan accounted for more than one-third share of the Asia-Pacific atrial fibrillation devices market in 2015
•The non-surgical equipment segment dominated in 2015, occupying largest revenue share and is anticipated to grow at a CAGR of 12.5%
•Catheter ablation (sub segment for surgical equipment) accounted for largest market share in 2015 and is anticipated to grow at a CAGR of 13.8%
•Cryoablation, a sub type of catheter ablation, is projecting the highest CAGR of 14.6% during the study period

North America accounted for the major share in the global atrial fibrillation devices market in 2015, and is expected to maintain its leading position throughout forecast period. This is attributable to the increase in prevalence of atrial fibrillation in geriatric population and high adoption of advanced technologies for the treatment of AF.

Key players have adopted product development as their key strategy to cater to the changing needs of the industry. Major players that operate in this market include Abbott Laboratories, Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, St. Jude Medical, Inc., Medtronic plc, Biotronik SE & Co. KG, Koninklijke Philips N.V., Siemens AG, and AtriCure Inc.

TABLE OF CONTENT:

Chapter: 1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2. EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

Chapter: 3. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.3. TOP WINNING STRATEGIES
3.4. PORTERS FIVE FORCES ANALYSIS

3.4.1. Bargaining power of suppliers
3.4.2. Bargaining power of buyers
3.4.3. Threat of new entrants
3.4.4. Competitive rivalry
3.4.5. Threat of substitutes
3.5. MARKET SHARE ANALYSIS, 2015
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Rising prevalence of atrial fibrillation in geriatric population
3.6.1.2. Technological advancements
3.6.1.3. Increasing preference of catheter ablation for cardiac arrhythmia treatment
3.6.2. Restraints
3.6.2.1. Dearth of skilled professionals
3.6.2.2. Unfavorable preference to pharmaceutical interventions (drugs) over AF treatment devices
3.6.3. Opportunities
3.6.3.1. Rising awareness of atrial fibrillation
3.6.3.2. Opportunities in emerging countries

Chapter: 4. ATRIAL FIBRILLATION MARKET, BY DEVICES
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SURGICAL DEVICES
4.2.1.1. Key market trends
4.2.1.2. Key growth factors and opportunities
4.2.2. Market size and forecast
4.2.2.1. MAZE surgery
4.2.2.2.Catheter ablation
4.3. NON-SURGICAL DEVICES
4.3.1. Key market trends
4.3.1.2. Key growth factors and opportunities
4.3.2. Market size and forecast
4.3.2.1. Electric cardioversion
4.3.2.2. Mapping and recording systems
4.3.2.3. Cardiac monitors
4.3.2.4. Access devices
4.3.2.5. Left Atrial Appendage (LAA) and closure devices
4.3.2.6. Intracardiac echocardiography (ICE) systems

Chapter: 5. ATRIAL FIBRILLATION MARKET, BY REGION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast
5.3. EUROPE
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. U.K. market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast
5.4. ASIA PACIFIC
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.3.1. Japan market size and forecast
5.4.3.2. India market size and forecast
5.4.3.3. China market size and forecast
5.4.3.4. Australia market size and forecast
5.4.3.5. South Korea market size and forecast
5.4.3.6. Rest of Asia-Pacific market size and forecast
5.5. LAMEA
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.3.1. Brazil market size and forecast
5.5.3.2. Argentina market size and forecast
5.5.3.3. Egypt market size and forecast
5.5.3.4. Israel market size and forecast
5.5.3.5. South Africa market size and forecast
5.5.3.6. Rest of LAMEA market size and forecast

Chapter: 6. COMPANY PROFILES
6.1. ABBOTT LABORATORIES
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Business performance
6.1.5. Key strategic moves & developments
6.2. JOHNSON & JOHNSON
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Business performance
6.2.5. Key strategic moves & developments
6.3. ATRICURE, INC.
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Business performance
6.3.5. Key strategic moves & developments
6.4. MICROPORT SCIENTIFIC CORPORATION
6.4.1. Company overview
6.4.2. Company Snapshot
6.4.3. Operating Business Segments
6.4.4. Business Performance
6.4.5. Key strategic moves & developments
6.5. BOSTON SCIENTIFIC CORPORATION
6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves & developments
6.6. ST. JUDE MEDICAL, INC.
6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves & developments
6.7. MEDTRONIC PLC
6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves & developments
6.8. BIOTRONIK SE & CO. KG
6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Key strategic moves & developments
6.9. KONINKLIJKE PHILIPS N.V.
6.9.1. Company overview
6.9.2. Philips- SNAPSHOT
6.9.3. Operating business segments
6.9.4. Business performance
6.9.5. Key strategic moves and developments

6.10. SIEMENS AG
6.10.1. Company overview
6.10.2. Siemens Healthcare- SNAPSHOT
6.10.3. Operating business segments
6.10.4. Financial performance
6.10.5. Key strategic moves and developments

Check offers and discount on this report @ https://www.alliedmarketresearch.com/get-discount/479

About Us:
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.